Sandostatin
Photos »
/ 
Related News »
The randomized, double-blind phase III study, PASPORT-ACROMEGALY (PASireotide clinical trial PORTfolio - ACROMEGALY), compared the efficacy and safety of pasireotide LAR with Sandostatin LAR (octreotide/IM injection) in 358 treatment naïve ...
May 9, 2012 at 16:44 | Source: Yahoo Finance
Patent expiries of blockbuster drugs such as Sandostatin LAR, Norditropin will restrict the growth of the market. The rapid uptake of novel dosage forms and formulations of existing drugs will increase the number of patients on treatment. Increased ...
May 16, 2012 at 10:02 | Source: pressreleasepoint.com
504.2.3 Sandostatin LAR (octreotide acetate) 514.3 Key Takeaway 515 Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment 525.1 Overview 525.2 Strategic Pipeline Assessment 525.3 Analysis by Phase of Development 535.3.1 Neuroendocrine ...
May 15, 2012 at 12:41 | Source: Yahoo Finance